Home   /   Taxonomy   /   Term

Healthcare

Broker's Calls

This healthcare stock is looking even more attractive at current price levels

SINGAPORE (Sept 18): CIMB Research is upgrading its call on Raffles Medical Group (RMG) to “add” from “reduce” with a lower price target of $1.21 from $1.25 previously on the belief that the stock is looking attractive to gain exposure to the grow

What does Rowsley’s plan to buy $1.9 bil in healthcare assets mean for investors?

This article appeared in Issue 790 (July 31) of The Edge Singapore

In print this week

How much will investors pay for Rowsley?

SINGAPORE (July 31): Billionaire former stockbroker Peter Lim is on his way to transforming Rowsley into a healthcare company — by injecting into the public-listed company assets that are already familiar to the market.

Emerging Markets

Asian EMs enjoy a supportive economic landscape with reasonable valuations: Deutsche

SINGAPORE (July 6): Deutsche Bank Wealth Management is retaining its “overweight” stance on emerging market (EM) equities, particularly Asia ex-Japan, as it deems the region’s economic landscape as supportive and its valuations reasonable.

Broker's Calls

CEO’s suspension a short term roadblock in TalkMed’s long term future, says RHB

SINGAPORE (June 29): RHB is maintaining its “buy” call on TalkMed Group with a lower target price of 73 cents from $1.03 previously following Wednesday’s news of the eight-month suspension of its CEO, Dr Ang Peng Tiam, starting from July 25.  

Senate GOP health proposal would leave 22 million uninsured

NEW YORK/WASHINGTON (June 27): Senate Republicans’ plan to replace Obamacare will increase the number of uninsured Americans by 22 million, raise costs for many people currently enrolled in private insurance and slash Medicaid by billions of dollars, ac

Singapore economy

How much is pain costing Singapore’s economy?

SINGAPORE (June 20): Pain conditions are costing Southeast Asian economies about US$44.6 billion ($61.9 billion) in productivity losses on an annual basis – out of which Singapore’s estimated productivity losses make up about US$6.2 billion per year,

Broker's Calls

Growth is a given for this leading healthcare stock, but the risks are still aplenty

SINGAPORE (June 5): Maybank Kim Eng Research is maintaining its “hold” call on IHH Healthcare with a higher price target of RM6.17 ($2) from RM5.62 previously, highlighting the stock as a healthcare leader in the premium hospital segment with a strong
Hossein Nejati, KroniKare

Startups, Entrepreneurs, Digital economy

AI startup KroniKare diagnoses wounds with smartphones

(May 31): As robots continue to displace factory workers and payment terminals replace cashiers, a Snapchat for the medical industry could change the way healthcare professionals work. Local start-up KroniKare is developing a mobile application that asses
The Evergrande-Wonjin Plastic Surgery Hospital on the outskirts of Tianjin

China's biggest developers are betting on US$2,400 nose jobs

(May 26): It’s called "Asia’s top-notch plastic surgery hospital," according to the promotional brochure for the grand, Chinese palace-style building near the port of Tianjin.
×